These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11801499)
1. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias. Kemp EG; Harnett AN; Chatterjee S Br J Ophthalmol; 2002 Jan; 86(1):31-4. PubMed ID: 11801499 [TBL] [Abstract][Full Text] [Related]
2. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Demirci H; McCormick SA; Finger PT Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099 [TBL] [Abstract][Full Text] [Related]
3. Topical mitomycin following cryotherapy for treatment of recurrent ocular surface melanoma. Rudkin AK; Muecke JS Can J Ophthalmol; 2009 Oct; 44(5):e41. PubMed ID: 19798814 [No Abstract] [Full Text] [Related]
4. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Kurli M; Finger PT Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485 [TBL] [Abstract][Full Text] [Related]
5. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis]. Werschnik C; Lommatzsch PK Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467 [TBL] [Abstract][Full Text] [Related]
6. Treatment of ocular surface squamous neoplasia with Mitomycin C. Gupta A; Muecke J Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963 [TBL] [Abstract][Full Text] [Related]
7. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops]. Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895 [TBL] [Abstract][Full Text] [Related]
8. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Shields CL; Naseripour M; Shields JA Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855 [TBL] [Abstract][Full Text] [Related]
9. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation. Siganos CS; Kozobolis VP; Christodoulakis EV Cornea; 2002 Jan; 21(1):12-6. PubMed ID: 11805500 [TBL] [Abstract][Full Text] [Related]
11. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Boehm MD; Huang AJ Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789 [TBL] [Abstract][Full Text] [Related]
13. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Daniell M; Maini R; Tole D Clin Exp Ophthalmol; 2002 Apr; 30(2):94-8. PubMed ID: 11886411 [TBL] [Abstract][Full Text] [Related]
14. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]. Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009 [TBL] [Abstract][Full Text] [Related]
16. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Russell HC; Chadha V; Lockington D; Kemp EG Br J Ophthalmol; 2010 Oct; 94(10):1316-21. PubMed ID: 20530655 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C. Tseng SH; Tsai YY; Chen FK Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697 [TBL] [Abstract][Full Text] [Related]
18. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Wilson MW; Hungerford JL; George SM; Madreperla SA Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356 [TBL] [Abstract][Full Text] [Related]
19. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences. Ditta LC; Shildkrot Y; Wilson MW Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia. Bahrami B; Greenwell T; Muecke JS Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]